These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10887996)
21. GM1 gangliosidosis in a Japanese domestic cat: a new variant identified in Hokkaido, Japan. Ueno H; Yamato O; Sugiura T; Kohyama M; Yabuki A; Miyoshi K; Matsuda K; Uchide T J Vet Med Sci; 2016 Jan; 78(1):91-5. PubMed ID: 26234889 [TBL] [Abstract][Full Text] [Related]
23. Canine GM1 gangliosidosis. An ultrastructural and biochemical study. Rodriguez M; O'Brien JS; Garrett RS; Powell HC J Neuropathol Exp Neurol; 1982 Nov; 41(6):618-29. PubMed ID: 6813429 [TBL] [Abstract][Full Text] [Related]
24. GM1 gangliosidosis in Portuguese water dogs: pathologic and biochemical findings. Saunders GK; Wood PA; Myers RK; Shell LG; Carithers R Vet Pathol; 1988 Jul; 25(4):265-9. PubMed ID: 3136586 [TBL] [Abstract][Full Text] [Related]
25. Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis. Weesner JA; Annunziata I; Yang T; Acosta W; Gomero E; Hu H; van de Vlekkert D; Ayala J; Qiu X; Fremuth LE; Radin DN; Cramer CL; d'Azzo A Cells; 2022 Aug; 11(16):. PubMed ID: 36010656 [TBL] [Abstract][Full Text] [Related]
26. GM1-gangliosidosis in American black bears: clinical, pathological, biochemical and molecular genetic characterization. Muthupalani S; Torres PA; Wang BC; Zeng BJ; Eaton S; Erdelyi I; Ducore R; Maganti R; Keating J; Perry BJ; Tseng FS; Waliszewski N; Pokras M; Causey R; Seger R; March P; Tidwell A; Pfannl R; Seyfried T; Kolodny EH; Alroy J Mol Genet Metab; 2014 Apr; 111(4):513-21. PubMed ID: 24581871 [TBL] [Abstract][Full Text] [Related]
27. Generalized CNS disease and massive GM1-ganglioside accumulation in mice defective in lysosomal acid beta-galactosidase. Hahn CN; del Pilar Martin M; Schröder M; Vanier MT; Hara Y; Suzuki K; Suzuki K; d'Azzo A Hum Mol Genet; 1997 Feb; 6(2):205-11. PubMed ID: 9063740 [TBL] [Abstract][Full Text] [Related]
28. Carrier Rate and Mutant Allele Frequency of GM1 Gangliosidosis in Miniature Shiba Inus (Mame Shiba): Population Screening of Breeding Dogs in Japan. Pervin S; Islam MS; Yorisada Y; Sakai A; Masamune S; Yabuki A; Rakib TM; Maki S; Tacharina MR; Yamato O Animals (Basel); 2022 May; 12(10):. PubMed ID: 35625088 [TBL] [Abstract][Full Text] [Related]
29. GM1 gangliosidosis: patients with different phenotypic features and novel mutations. Emecen Sanli M; Dogan M J Pediatr Endocrinol Metab; 2023 Jun; 36(6):602-607. PubMed ID: 37042746 [TBL] [Abstract][Full Text] [Related]
30. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis]. Inui K Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066 [TBL] [Abstract][Full Text] [Related]
31. Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia. Uyama E; Terasaki T; Watanabe S; Naito M; Owada M; Araki S; Ando M Acta Neurol Scand; 1992 Dec; 86(6):609-15. PubMed ID: 1336295 [TBL] [Abstract][Full Text] [Related]
32. Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content. Tonin R; Caciotti A; Procopio E; Fischetto R; Deodato F; Mancardi MM; Di Rocco M; Ardissone A; Salviati A; Marangi A; Strisciuglio P; Mangone G; Casini A; Ricci S; Fiumara A; Parini R; Pavone FS; Guerrini R; Calamai M; Morrone A Sci Rep; 2019 Nov; 9(1):17684. PubMed ID: 31776384 [TBL] [Abstract][Full Text] [Related]
33. AAV9-coGLB1 Improves Lysosomal Storage and Rescues Central Nervous System Inflammation in a Mutant Mouse Model of GM1 Gangliosidosis. Liu S; Ma W; Feng Y; Zhang Y; Jia X; Tang C; Tang F; Wu X; Huang Y Curr Gene Ther; 2022; 22(4):352-365. PubMed ID: 35249485 [TBL] [Abstract][Full Text] [Related]
34. Ultrastructural lesions of ovine GM1 gangliosidosis. Murnane RD; Ahern-Rindell AJ; Prieur DJ Mod Pathol; 1991 Nov; 4(6):755-62. PubMed ID: 1788267 [TBL] [Abstract][Full Text] [Related]
35. Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation. Kajihara R; Numakawa T; Odaka H; Yaginuma Y; Fusaki N; Okumiya T; Furuya H; Inui S; Era T Stem Cell Reports; 2020 May; 14(5):909-923. PubMed ID: 32302553 [TBL] [Abstract][Full Text] [Related]
36. Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan. Weismann CM; Ferreira J; Keeler AM; Su Q; Qui L; Shaffer SA; Xu Z; Gao G; Sena-Esteves M Hum Mol Genet; 2015 Aug; 24(15):4353-64. PubMed ID: 25964428 [TBL] [Abstract][Full Text] [Related]
37. Pathological findings of central nervous system, two GM1 gangliosidosis autopsy cases. Kara DÖ; Şahpaz A Turk J Pediatr; 2019; 61(6):953-957. PubMed ID: 32134593 [TBL] [Abstract][Full Text] [Related]
38. Type III (chronic) GM1-gangliosidosis. Histochemical and ultrastructural studies of rectal biopsy. Ushiyama M; Ikeda S; Nakayama J; Yanagisawa N; Hanyu N; Katsuyama T J Neurol Sci; 1985 Dec; 71(2-3):209-23. PubMed ID: 3936902 [TBL] [Abstract][Full Text] [Related]
39. GM2-gangliosidosis variant 0 (Sandhoff-like disease) in a family of Japanese domestic cats. Yamato O; Matsunaga S; Takata K; Uetsuka K; Satoh H; Shoda T; Baba Y; Yasoshima A; Kato K; Takahashi K; Yamasaki M; Nakayama H; Doi K; Maede Y; Ogawa H Vet Rec; 2004 Dec; 155(23):739-44. PubMed ID: 15623087 [TBL] [Abstract][Full Text] [Related]
40. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion. Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]